Scientific Paper

The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian…

April 27, 2023

The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian…

Back to Resources

At Atuka, we combine our capabilities with yours to harness the power of partnership and advance your therapeutic program.

Talk to a Neuroscience Expert